References
- McArthurJCBrewBJNathANeurological complications of HIV infectionLancet Neurol20054954355516109361
- SchmaderKEEpidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathyClin J Pain200218635035412441828
- O’ConnorABDworkinRHTreatment of neuropathic pain: an overview of recent guidelinesAm J Med200912210 SupplS22S32
- WoolfCJMannionRJNeuropathic pain: aetiology, symptoms, mechanisms, and managementLancet199935391681959196410371588
- CaterinaMJJuliusDThe vanilloid receptor: a molecular gateway to the pain pathwayAnnu Rev Neurosci20012448751711283319
- CortrightDNSzallasiABiochemical pharmacology of the vanilloid receptor TRPV1. An updateEur J Biochem2004271101814181915128291
- FacerPCasulaMASmithGDDifferential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathyBMC Neurol200771117521436
- MaWZhangYBantelCEisenachJCMedium and large injured dorsal root ganglion cells increase TRPV-1, accompanied by increased alpha2C-adrenoceptor co-expression and functional inhibition by clonidinePain2005113338639415661448
- BleyKRTRPV1 agonist approaches for pain managementGomtsyanAFaltynekCRVanilloid Receptor TRPV1 in Drug DiscoveryHoboken, NJJohn Wiley & Sons, Inc2010325347
- KennedyWRVanhoveGFLuSPA randomized, controlled, openlabel study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteersJ Pain201011657958720400377
- SzallasiABlumbergPMVanilloid (capsaicin) receptors and mechanismsPharmacol Rev199951215921210353985
- BackonjaMMWallaceMSBlonskyERNGX-4010, a high- concentration capsaicin patch, for the treatment of postherpetic neuralgia: A randomised, double-blind studyLancet Neurol20087121106111218977178
- BackonjaMMMalanTPVanhoveGFTobiasJKNGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an openlabel extensionPain Med201011460060820113411
- IrvingGABackonjaMMDuntemanEA multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgiaPain Med20111219910921087403
- SimpsonDMBrownSTobiasJControlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathyNeurology200870242305231318541884
- WebsterLRMalanTPTuchmanMMMollenMDTobiasJKVanhoveGFA multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgiaJ Pain2010111097298220655809
- SimpsonDMGazdaSBrownSLong-term safety of NGX- 4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic painJ Pain Symptom Manage20103961053106420538187
- BabbarSMarierJFMouksassiMSPharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic painTher Drug Monit200931450251019494795
- GustoffBFirst experience with QUTENZA: Case reportsInternational Association for the Study of Pain 13th World Congress on Pain2010Montreal, QC Discussion
- FarrarJTYoungJPJrLaMoreauxLWerthJLPooleRMClinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scalePain200194214915811690728
- WebsterLRTarkMRauckRTobiasJKVanhoveGFEffect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgiaBMC Neurol2010109220937130
- WallaceMPappagalloMQutenza®: A capsaicin 8% patch for the management of postherpetic neuralgiaExpert Rev Neurother2011111152721158551
- EcclestonCRole of psychology in pain managementBr J Anaesth200187114415211460803
- JohnsonMHHow does distraction work in the management of pain?Curr Pain Headache Rep200592909515745617
- LintonSJMcCrackenLMVlaeyenJWReassurance: help or hinder in the treatment of painPain20081341–25818035496
- BackonjaMMWalkDEdwardsRRQuantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalitiesClin J Pain200925764164719692807